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Background: Perioperative myocardial infarction (PMI) and prognostically relevant myocardial injury following non-cardiac 
surgery (MINS) increases perioperative mortality. Studies in vascular patients show an increased incidence and mortality from 
PMI. However, there remains limited data on the relative prognostic importance of PMI and MINS in South African vascular 
surgical patients. The primary objective was to evaluate the incidence and prognosis of PMI and MINS in vascular surgical patients 
admitted to intensive care. The secondary objective was to identify predictors of PMI and hospital mortality.
Methods: A retrospective electronic patient record review of all patients aged at least 45 years admitted to Inkosi Albert Luthuli 
Central Hospital (IALCH) intensive care unit (ICU) following vascular surgery between 1 January 2011 and 31 December 2013 was 
carried out.
Results: A total of 140 vascular patients were reviewed; 24.3% of the patients had a PMI and a further 25% had MINS. PMI was 
associated with significantly increased hospital mortality of 58.8% (p < 0.01) and MINS was not (20%, p = 1.00). Increasing age, the 
highest postoperative B-type natriuretic peptide (BNP) and a blood transfusion within the first three days postoperatively were 
independent predictors of PMI. PMI and a history of congestive cardiac failure were independent predictors of hospital mortality.
Conclusion: PMI and MINS are present in nearly 50% of vascular patients admitted to intensive care postoperatively. PMI but not 
MINS in these patients was significantly associated with hospital mortality. MINS requires strict diagnostic criteria in the intensive 
care where other non-ischaemic pathologies may be associated with myocardial injury.
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Introduction
Of the estimated 312 million adults globally that undergo 
surgery annually,1 approximately 100 million have non-cardiac 
surgery, are at least 45 years old and at risk of PMI or myocardial 
injury.2 Following non-cardiac surgery, approximately 3.3 million 
patients have a perioperative myocardial infarction (PMI) and 4.6 
million have myocardial injury after non-cardiac surgery (MINS).2 
MINS by definition is myocardial injury (as reflected by 
postoperative troponin elevation), which is deemed to be 
secondary to myocardial ischaemia, and does not fulfil the 
Universal Definition of Myocardial Infarction.3 The estimated 30-
day mortality for MINS is 7.8% and up to 12.5% for PMI.2
The multinational Vascular events In noncardiac Surgery patIents 
cOhort evaluatioN (VISION) Study4 showed that the peak 
troponin T (TnT) value within the first 3 days of surgery was the 
strongest independent predictor of 30-day mortality with a 
population-attributable risk of 41.8%. Monitoring TnT for the first 
3 days following surgery substantially improved 30-day mortality 
risk stratification when compared with a predictive model limited 
to preoperative risk factors only, with a net reclassification 
improvement of 25.0% (p < 0.001). The Third Universal Definition 
of Myocardial Infarction5 recommends that the term acute 
myocardial infarction (MI) should be used when there is evidence 
of ‘myocardial necrosis in a clinical setting consistent with acute 
myocardial ischaemia’. It is essential to recognise that the 
perioperative clinical setting often confounds or limits the 
clinician’s ability to make a diagnosis based on these criteria, as 
patients are often asymptomatic due to systemic analgesics and 
postoperative intensive care patients may be sedated and 
ventilated. Fundamentally, the Universal Definition of MI may 
therefore be flawed in determining postoperative patients at risk 
of cardiovascular complications by explicitly excluding patients 
with prognostically relevant perioperative myocardial ischaemic 
insults where the troponin elevation is above the 99th percentile 
for the upper reference limit (URL), but the postoperative clinical 
scenario prevents a diagnosis of myocardial infarction. For this 
reason, Myocardial Injury after Noncardiac Surgery (MINS) was 
defined, and described as a ‘prognostically relevant myocardial 
injury due to ischaemia that occurs during or within 30 days after 
noncardiac surgery’.3 In the MINS3 study, 58.2% of the patients 
who experienced MINS did not meet the Third Universal 
Definition criteria for an MI and nearly 85% of the patients were 
asymptomatic with no ischaemic symptoms. MINS was an 
independent predictor of 30-day mortality with the highest 
population attributable risk of all the perioperative complications 
for 30-day mortality (34.0%, 95% CI 26.6–41.5). The Vascular 
events In noncardiac Surgery patIents cOhort evaluatioN 
(VISION) Study4 showed that the majority of MINS occurred 
during the first two days following surgery when most patients 
are receiving analgesics that may mask ischaemic pain.
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A number of studies have emphasised the importance of 
postoperative troponin elevation in vascular surgical patients. A 
meta-analysis6 showed that an isolated troponin leak was 
present in 10.2% of vascular surgical patients and 6.3% had a 
PMI, and both an isolated troponin leak and PMI were associated 
with an increased 30-day mortality. A peak postoperative 
troponin I (TnI) level above the URL has been significantly 
associated with increased mortality at 2.5  years following 
vascular surgery. Postoperative troponin levels more than three 
times the URL outperformed clinical risk prediction variables.7 
When the absolute change in highly sensitive cardiac troponin T 
(hsTnT) within the first 24 postoperative hours of vascular surgery 
was added to the Revised Cardiac Risk Index (RCRI), the predictive 
accuracy of the score was significantly improved.8
The incidence of PMI or MINS and its impact on hospital mortality 
in the postoperative vascular surgical patient requiring intensive 
care in a South African context has not been described. Non-
cardiac patients in the intensive care unit (ICU) have been 
reported to have a high incidence of postoperative troponin 
elevation with 84% of patients with hsTnT above the 99th 
percentile.9 Furthermore, the relationship between other 
biomarkers, postoperative predictors of cardiac complications 
and postoperative troponin elevation is poorly understood. 
Elevated brain natriuretic peptide (BNP) and N-terminal fragment 
BNP measured within 7 days following non-cardiac surgery were 
shown to be independent predictors of a composite of mortality 
and non-fatal myocardial infarction, mortality, cardiac mortality 
and cardiac failure at 30 and ≥ 180 days,10 while a perioperative 
blood transfusion was an independent predictor of postoperative 
cardiac complications.11 The diagnosis of MINS requires exclusion 
of other causes of troponin elevation, in order to attribute the 
troponin leak to myocardial ischaemia. Other factors such as 
early sepsis or postoperative inotropic requirements may, 
however, result in early troponin release, which may compromise 
the prognostic importance of MINS in intensive care patients.
The objectives of this study were therefore to determine the 
incidence of perioperative myocardial infarction (PMI) or MINS 
and the associated hospital mortality in vascular surgical patients 
requiring postoperative intensive care.
Methods
This is a retrospective observational cohort study of patients 
aged 45  years or older who were admitted to ICU 2 at Inkosi 
Albert Luthuli Central Hospital (IALCH) following vascular surgery 
between 1 January 2011 and 31 December 2013. Where patients 
were admitted more than once to the intensive care unit, we 
analysed only the first admission. This is a closed surgical 
intensive care unit in a quaternary level central hospital in 
Durban, KwaZulu-Natal. An a priori decision was taken to include 
only patients aged ≥ 45 years in the study, to ensure consistency 
with the published literature.3,4 PMI was defined according to the 
2012 Third Universal Definition of Myocardial Infarction by the 
ESC/ACCF/AHA/WHF Taskforce,5 as the detection of a rise and/or 
fall of cardiac biomarker values with at least one value above the 
99th percentile URL and with one of the following criteria: 
symptoms of ischaemia, new or presumed new ischaemic ECG 
changes, imaging evidence of new loss of viable myocardium or 
new regional wall motion abnormality or identification of an 
intracoronary thrombus by angiography or autopsy.
Troponin I (TnI) is the assay clinically available at IALCH and is 
measured routinely, as per unit policy, during the patient’s ICU 
stay. The peak levels on days 0–3 postoperatively were extracted. 
Postoperative ECGs were adjudicated for PMI, and if they were 
not available, the ECG changes recorded in the patient’s medical 
chart were used in the adjudication for PMI. The echocardiogram 
reports were used in the analysis. Angiography or autopsy results 
were reviewed, if necessary. Patients who were intubated and on 
a ventilator were unable to report symptoms of ischaemia.
A TnI elevation in the first 3 days postoperatively that was above 
the assay-specific laboratory normal threshold of 40 ng/l (99th 
percentile of URL) but below the diagnostic threshold of 600 ng/l 
for myocardial infarction, and adjudicated to be due to an 
ischaemic cause, was categorised as MINS. All known non-
ischaemic causes of troponin elevation were excluded from the 
MINS categorisation. The preoperative brain natriuretic peptide 
(BNP) and the highest value in the first three  days following 
surgery were extracted. The patient’s lowest haemoglobin, 
whether the patient was transfused red cell concentrate and the 
number of units transfused within the first three postoperative 
days were extracted. Mechanical ventilation and use of inotropes 
(adrenaline or dobutamine) within the first three days following 
surgery was also extracted.
The patient demographics and preoperative risk predictors of 
cardiovascular disease (age, gender, history of diabetes mellitus, 
hypertension, ischaemic heart disease, congestive cardiac 
failure, previous coronary revascularisation, previous 
cerebrovascular accident, smoking within six  months) were 
recorded. Due to the retrospective nature of this study, patients 
were not routinely followed up after hospital discharge, and it 
was therefore impossible to evaluate the 30-day mortality for all 
patients. The primary outcome was therefore hospital mortality. 
Surgical factors are also presented.
Data sources/measurement
The Siemens ADVIA Centaur XP® Immunoassay System 
(Tarrytown, NY, USA) was used by the laboratory. The TnI-
Ultra® and the Centaur XP® kits were used for troponin I analysis 
and the Centaur BNP® used for BNP analysis. According to the 
scorecard concept,12 if a troponin assay meets two proposed 
criteria it is regarded as a ‘high-sensitivity’ assay. The total 
imprecision (coefficient of variation) at the 99th percentile value 
should be < 10% and, second, levels below the 99th percentile 
should be measurable in at least 50% of healthy individuals.12,13 
The troponin assays in the Siemens ADVIA Centaur XP® 
Immunoassay System are classified as contemporary 
sensitive.12–14 The TnI assay used meets the criteria of  <  10% 
imprecision at the 99th percentile URL and as recommended by 
the Third Universal Definition of MI, the manufacturer defined 
99th percentiles URL were used.
Statistical methods
SPSS® package version 22 (IBM Corp, Armonk, NY, USA) was used 
for the analysis. The categorical data were analysed using the chi-
squared distribution table while the unpaired Student’s t-test 
was used for continuous data and the Mann–Whitney U test for 
non-parametric data. A p-value < 0.05 was considered statistically 
significant. An a priori decision was taken to include PMI, MINS 
and postoperative BNP in a multivariate logistic regression for 
hospital mortality. In order not to violate the rule of 10 events per 
variable,15 only the preoperative characteristics with a univariate 
association with hospital mortality or PMI were also included in 
the multivariate logistic regression. Results are reported as odds 
ratios (OR) and 95% confidence intervals (CI).
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Results
Figure 1 shows the patients included in this study. A total of 212 
individual patient electronic records were reviewed for extraction 
of the relevant data. Patients with the following non-ischaemic 
causes of troponin elevation were excluded from the MINS 
cohort: pulmonary embolism (n = 2), post-CPR (n = 2), cardiac 
contusion n = (2).
The patient characteristics are given in Table 1. The mean age 
was 61.7 years and 73.6% were male. Hypertension was the most 
prevalent cardiovascular risk factor, followed by smoking, 
diabetes mellitus, previous cerebrovascular accident, history of 
ischaemic heart disease and congestive cardiac failure. Survivors 
and non-survivors were similar with the exception that the 
patients who died had significantly more congestive cardiac 
failure. Emergency surgery was performed in 17.8% of the 
patients and this was associated with a significantly increased 
hospital mortality of 37.8%. The most common site of surgery 
was carotid (34.3%), followed by aorta (21.4%), aorta-iliac (20%) 
and infra-inguinal (23.6%). Infra-inguinal surgery was associated 
with significantly increased hospital mortality of 45% (p = 0.01). 
Patients that were mechanically ventilated or on inotropes in the 
first three  days postoperatively had a significantly increased 
hospital mortality (p < 0.01). In patients with MINS, there was a 
significantly increased inotrope dependence within the first 
three days postoperatively (p = 0.03).
Within the study population, 25% were classified as having MINS 
and 24.3% a PMI. The overall hospital mortality for the study 
population was 28.6%. The hospital mortality in the MINS group 
was not significantly different from patients without an isolated 
troponin leak (p = 1.00). PMI was associated with significantly 
increased hospital mortality (58.8% vs. 18.3%, p < 0.001). The 
multivariate analyses of the predictors of hospital mortality and 
PMI are given in Tables 2 and 3 respectively. PMI and a history of 
congestive cardiac failure were independent predictors of 
hospital mortality. The median postoperative BNP in the total 
population was 210  ng/l (IQR = 72.5–462). The postoperative 
BNP was significantly higher in non-survivors (p = 0.04) but it was 
not an independent predictor of mortality. MINS was not 
associated with hospital mortality.
The median BNP of 920 ng/l (IQR = 217–1822) in patients with a 
PMI was significantly increased (p < 0.001) compared with the 
median BNP of 144  ng/l (IQR = 49–316) in those without a 
troponin elevation. The patient’s age, postoperative BNP and the 
need for a postoperative blood transfusion were independent 
predictors of a PMI (see Table 3).
Discussion
The main findings of this study are that in vascular surgical 
patients requiring postoperative intensive care at IALCH, the 
incidence of postoperative troponin elevation approaches 50%, 
although only 24.3% fulfil the Third Universal Definition of MI. 
While those patients who fulfilled the Third Universal Definition 
of MI were at a significantly increased risk of mortality, patients 
with MINS were not.
The incidence of troponin elevation in our vascular patients 
requiring intensive care admission is similar to other vascular 
intensive care cohorts.7 The reported incidence of PMI in vascular 
patients of between 5% and 26.5%6,16 is comparable to the 24.3% 
found in our patients. The finding that PMI and a history of 
congestive cardiac failure were independent predictors of 
hospital mortality is consistent with the VISION4 study. The 
significantly increased hospital mortality in those with a PMI is 
consistent with the hospital mortality of another study in 
vascular surgery patients.16
An important difference from the published literature3 is that 
MINS in our patients was not independently associated with 
increased mortality. There are a number of possible reasons for 
this, and they have important implications for clinical 
management in the intensive care unit. In the MINS study by 
Botto et al.3 fourth-generation troponin T levels above 0.03 ng/
ml were determined as the diagnostic threshold for MINS. This 
was below the abnormal laboratory threshold at the time of the 
study. While an abnormal troponin elevation adjudicated to be 
Figure 1: Patient flow chart.
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Furthermore, the diagnosis of MINS requires exclusion of non-
ischaemic causes of troponin elevation, which may be clinically 
difficult in the early postoperative period in intensive care patients. 
There are also many non-ischaemic factors, e.g. myocarditis, 
pericarditis, cardiac failure, vasopressor use, pulmonary disease, 
intracranial events (e.g. haemorrhage) and sepsis, that may lead to 
troponin release in critical illness.9 In a study of critically ill patients, 
BNP and TnI levels were significantly higher in those with sepsis or 
septic shock.17 There were four patients (11.4%) in our MINS group 
that had coexisting sepsis during the first three  days of ICU 
admission which may have led to troponin release. Another 
potential confounder for MINS in intensive care may be inotropes, 
which were used in 48.6% of our study patients.
BNP elevation may help in distinguishing between ischaemic-
associated MINS and non-ischaemic aetiologies of troponin 
release in the early postoperative period in the intensive care 
unit. After 24 hours in the critically ill patient with sepsis, the BNP 
level has been shown to be significantly associated with ICU 
mortality17 and at days 3 and 4 with left ventricular systolic 
dysfunction.17 However, in our patients an early elevated BNP 
was associated only with PMI. In patients with suspected MINS in 
intensive care, evaluation of an early BNP may be necessary to 
identify patients at risk of PMI (as in our study) or ICU mortality 
and a later elevation may, rather, suggest a septic patient with 
myocardial dysfunction.17
While a blood transfusion predicted an increased risk of a PMI, it was 
not associated with increased hospital mortality. The evidence on 
the prognostic impact of postoperative blood transfusion is 
variable, depending on the patient population and the periopera- 
tive setting. The transfusion practices in the present study were 
clinician directed with no specified transfusion triggers or target, 
which may account for it not being a predictor of hospital mortality.
Limitations
Our study may be underpowered to determine the prognostic 
significance of MINS in vascular surgical intensive care patients, 
or the importance of postoperative BNP for hospital mortality.
due to ischaemia was classified as MINS in our study, there are no 
validated troponin I reference values for MINS. The use of the URL 
for troponin I may be inappropriate and this needs to be 
addressed urgently.
Table 1: Patient demographics and perioperative risk factors
*Standard deviation.
†Myocardial injury following non-cardiac surgery.




Factor Total Survivors Non-
survivors 
p-value
n (%) n (%) n (%)
100 (71.4) 40 (28.6)
Preoperative risk factors
Age: mean 
(SD)* 61.7 (9) 60.9 (8.5) 63.8 (10.1) 0.085
Gender: male 103 (73.6) 74 (74.0) 29 (72.5) 0.84
Diabetic 53 (37.8) 37 (37) 16 (40) 0.85
Hypertensive 105 (75) 72 (72) 33 (82.5) 0.28
Ischaemic 
heart disease 44 (31.4) 29 (29) 15 (37.5) 0.42
Congestive 
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Surgical risk factors
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35 (25) 28 (80.0) 7 (20.0) 1.00‡
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53 (37.85) 35 (35) 18 (45) 0.33
Table 2: Independent predictors of hospital mortality
*Odds ratio.
†Confidence interval.
‡Myocardial injury following non-cardiac surgery.
§Perioperative myocardial infarction.
||Brain natriuretic peptide.
Variable OR* (95% CI)† p-value
Congestive cardiac failure 5.51 (1.13–26.87) 0.03
MINS‡ 1.06 (0.36–3.10) 0.91
PMI§ 4.3 (1.43–12.94) 0.01
Postoperative BNP|| within the first 3 days 1.0 (1.00–1.00) 0.17





Variable OR* (95% CI)† p-value
Age 1.07 (1.00–1.13) 0.04
Postoperative BNP‡ within the first 3 days 1.00 (1.00–1.01) < 0.001
Postoperative transfusion within the first 
3 days 3.96 (1.24–12.68) 0.02
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for troponin I may be inappropriate and this needs to be 
addressed urgently.
Table 1: Patient demographics and perioperative risk factors
*Standard deviation.
†Myocardial injury following non-cardiac surgery.




Factor Total Survivors Non-
survivors 
p-value
n (%) n (%) n (%)
100 (71.4) 40 (28.6)
Preoperative risk factors
Age: mean 
(SD)* 61.7 (9) 60.9 (8.5) 63.8 (10.1) 0.085
Gender: male 103 (73.6) 74 (74.0) 29 (72.5) 0.84
Diabetic 53 (37.8) 37 (37) 16 (40) 0.85
Hypertensive 105 (75) 72 (72) 33 (82.5) 0.28
Ischaemic 
heart disease 44 (31.4) 29 (29) 15 (37.5) 0.42
Congestive 












67 (47.8) 50 (50) 17 (42.5) 0.46
Surgical risk factors
Emergency 





















35 (25) 28 (80.0) 7 (20.0) 1.00‡
PMI§ (≥ 












53 (37.85) 35 (35) 18 (45) 0.33
Table 2: Independent predictors of hospital mortality
*Odds ratio.
†Confidence interval.
‡Myocardial injury following non-cardiac surgery.
§Perioperative myocardial infarction.
||Brain natriuretic peptide.
Variable OR* (95% CI)† p-value
Congestive cardiac failure 5.51 (1.13–26.87) 0.03
MINS‡ 1.06 (0.36–3.10) 0.91
PMI§ 4.3 (1.43–12.94) 0.01
Postoperative BNP|| within the first 3 days 1.0 (1.00–1.00) 0.17





Variable OR* (95% CI)† p-value
Age 1.07 (1.00–1.13) 0.04
Postoperative BNP‡ within the first 3 days 1.00 (1.00–1.01) < 0.001
Postoperative transfusion within the first 
3 days 3.96 (1.24–12.68) 0.02
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The retrospective nature of the study did limit the information 
that was available for analysis. The reasons for admission to the 
ICU were not extracted but the higher level of organ support and 
monitoring could indicate a greater severity of illness compared 
with a vascular surgery patient who is cared for in a general ward. 
The site of surgery and surgical urgency were not included in the 
multivariate analyses, and these may have an impact on the 
prognosis of the patient.
Generalisability
The study group represents the typical South African vascular 
surgical population with their underlying risk of perioperative 
complications. It may not be applicable to the vascular surgical 
population as a whole, but rather those who require ICU 
admission for organ support or intensive monitoring.
Conclusion
PMI and MINS were present in nearly half of the vascular surgery 
patients requiring postoperative ICU admission. Patients with a 
PMI have a significantly increased hospital mortality. In patients 
with suspected MINS, an early postoperative BNP may help 
accurately identify patients at risk of PMI.
The correct identification of MINS in these vascular surgical 
intensive care patients is difficult, due to the use of inotropes, a 
high incidence of subclinical sepsis, and no clearly defined 
diagnostic troponin thresholds for MINS. Urgent research in this 
area is needed.
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